Anzeige
Mehr »
Donnerstag, 17.07.2025 - Börsentäglich über 12.000 News
Klinisch validiert. Vertriebsbereit. Und kurz vor der FDA-Zulassung.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41BED | ISIN: SE0024173637 | Ticker-Symbol: 7AL0
Frankfurt
17.07.25 | 08:00
0,474 Euro
-0,13 % -0,001
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ALLIGATOR BIOSCIENCE AB Chart 1 Jahr
5-Tage-Chart
ALLIGATOR BIOSCIENCE AB 5-Tage-Chart

Aktuelle News zur ALLIGATOR BIOSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoAlligator Bioscience Comments on Henlius Dosing First Patient in the US in Phase 3 Trial of HLX22 in Gastric Cancer147LUND, SWEDEN / ACCESS Newswire / July 14, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today comments on the announcement by Shanghai Henlius Biotech, Inc. that it has dosed the first patient...
► Artikel lesen
10.07.Alligator Bioscience: Operativer Verlust in Q2 2025 belastet Aktienkurs2
10.07.Alligator Bioscience AB Reports Financial Results for Q2 2025 and Provides a Business Update491GMP manufacturing completed, paediatric waiver granted, positive outcome from FDA and EMA interactions; advancing mitazalimab toward Phase 3 readinessBiomarker data from OPTIMIZE-1 presented at ASCO...
► Artikel lesen
01.07.Alligator Bioscience: Alligator to Present 24-Month OPTIMIZE-1 Data at ESMO GI 2025232LUND, SWEDEN / ACCESS Newswire / July 1, 2025 / Alligator Bioscience (Nasdaq Stockholm: ATORX), a clinical-stage biotechnology company developing tumor-directed immunotherapies, today announced that...
► Artikel lesen
30.06.Change in Number of Shares and Votes in Alligator Bioscience AB198LUND, SWEDEN / ACCESS Newswire / June 30, 2025 / During June 2025, the number of shares and votes in Alligator Bioscience AB (STO:ATORX) ("Alligator Bioscience")has increased as a result of the exercise...
► Artikel lesen
17.06.Alligator Bioscience: Alligator Receives Positive Scientific Advice from EMA on Phase 3 Trial of Mitazalimab374LUND, SE / ACCESS Newswire / June 17, 2025 / Alligator Bioscience (STO:ATORX) - Lund, Sweden, 17 June 2025 - Alligator Bioscience (Nasdaq Stockholm: ATORX), a clinical-stage biotechnology company developing...
► Artikel lesen
13.06.Alligator Bioscience Receives FDA Endorsement of Mitazalimab Phase 3 Dose for Pancreatic Cancer275LUND, SE / ACCESS Newswire / June 13, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immunotherapies, today announced that the...
► Artikel lesen
ALLIGATOR BIOSCIENCE Aktie jetzt für 0€ handeln
03.06.Biomarker Data from Alligator Bioscience's OPTIMIZE-1 Trial Presented at ASCO 2025 Annual Meeting200LUND, SE / ACCESS Newswire / June 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced that biomarker data from its OPTIMIZE-1 clinical trial were presented at the 2025 American Society...
► Artikel lesen
26.05.Alligator Bioscience AB Carries Out Directed Issues to Guarantors in Connection with Exercise of Warrants Series TO 12378LUND, SE / ACCESS Newswire / May 26, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA...
► Artikel lesen
26.05.Alligator Bioscience Announces European Orphan Drug Designation for HLX22 in Gastric Cancer356LUND, SE / ACCESS Newswire / May 26, 2025 / Alligator Bioscience (STO:ATORX) - Lund, Sweden - 26 May 2025 - Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the European Commission...
► Artikel lesen
23.05.Alligator Bioscience Presents OPTIMIZE-1 Biomarker Data at ASCO 2025 Annual Meeting319LUND, SE / ACCESS Newswire / May 23, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced the presentation of biomarker data from its OPTIMIZE-1 clinical trial at the 2025 American Society...
► Artikel lesen
21.05.Alligator Bioscience AB Announces Final Outcome of Exercise of Warrants Series TO 12229LUND, SE / ACCESS Newswire / May 21, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA...
► Artikel lesen
20.05.Alligator Bioscience Announces Paediatric Study Waiver for Mitazalimab Granted by the European Medicines Agency281LUND, SE / ACCESS Newswire / May 20, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical stage biotechnology company pioneering immuno-oncology therapeutics, today announced that the European...
► Artikel lesen
20.05.Alligator Bioscience AB Announces Preliminary Outcome of Exercise of Warrants Series TO 12254LUND, SE / ACCESS Newswire / May 20, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA...
► Artikel lesen
15.05.Last Day of Trading in Warrants Series TO 12 in Alligator Bioscience is 15 May 2025265LUND, SE / ACCESS Newswire / May 15, 2025 / Alligator Bioscience (STO:ATORX)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA...
► Artikel lesen
12.05.Alligator Bioscience to Attend ASCO 2025 Annual Meeting296LUND, SE / ACCESS Newswire / May 12, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) is pleased to announce that data from its OPTIMIZE-1 clinical trial will be presented at the 2025 American Society...
► Artikel lesen
09.05.Alligator Bioscience Announces that 85% of the Warrant Programme TO 12 has Been Secured and that the Outstanding Loan has Been Renegotiated342NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
09.05.Alligator Bioscience Completes Phase 3 GMP Manufacturing of Mitazalimab, Remains on Track for Trial Initiation with Partner341LUND, SE / ACCESS Newswire / May 9, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced the successful completion of the manufacture of the first GMP drug product batch of its lead...
► Artikel lesen
08.05.Alligator Bioscience Updates Dividend Policy248LUND, SE / ACCESS Newswire / May 8, 2025 / Alligator Bioscience (STO:ATORX) - Alligator Bioscience AB (publ) today announces an update to its dividend policy following the constitution of Alligator's...
► Artikel lesen
07.05.Bulletin from the Annual General Meeting in Alligator Bioscience AB on 7 May 2025264LUND, SE / ACCESS Newswire / May 7, 2025 / Alligator Bioscience (STO:ATORX) - The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation...
► Artikel lesen
Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3